MRI-efficacy of Abatacept in patients with rheumatoid arthritis [MIYAKO study]
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms MIYAKO study
- 02 Feb 2016 Status changed from active, no longer recruiting to completed according to results presented at the 79th American College of Rheumatology and the 50th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 28 Feb 2015 Planned number of patients changed from 40 to NULL.
- 28 Feb 2015 New trial record